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Edited by Peter BrzezinskiAbstract The cationic peptide tritrpticin (VRRFPWWWP-
FLRR, Trp3) has a broad action spectrum, acting against
Gram-positive and Gram-negative bacteria, as well as some fungi,
while also displaying hemolytic activity. We have studied the
behavior ofTrp3 in planar lipid bilayers (or black lipidmembrane –
BLM) and were able to demonstrate its ion channel-like activity.
Channel-like activity was observed in negatively charged azolectin
BLMas a sudden appearance of discrete current ﬂuctuations upon
application of a constant voltage across the membrane. Trp3
formed large conductance channels (500–2000 pS) both at positive
and negative potentials. In azolectin bilayers, the predominant ion-
channel activity was characterized by very regular and discrete
current steps (corresponding to openings) of uniform amplitude,
which exhibited relatively long residence times (of the order of
seconds).Occasionally, multiple conductance steps were observed,
indicating the simultaneous presence of more than one open pore.
In bilayers of zwitterionic diphytanoylphosphatidyl choline
(DPhPC) Trp3 also showed ion-channel activity, but in a much
less frequent and less prominent way. Studies of ion selectivity
indicated that Trp3 forms a cation-selective channel. These results
should contribute to the understanding of the molecular interac-
tions and mechanism of action of Trp3 in lipid bilayers and
biological membranes.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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A vast variety of organisms from both vegetal and animal
kingdoms produces substances whose main function is de-
fense against invading pathogenic micro-organisms. An im-* Corresponding author. Fax: +55-11-3091-2179.
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Abbreviations: Boc, tert-butyloxycarbonyl; For, formyl; HPLC, high
performance liquid chromatography; DOPC, dioleoylphosphatidyl
choline; DOPE, dioleoylphosphatidyl ethanolamine; DOPG, dioleoyl-
phosphatidyl glycerol; DPhPC, diphytanoylphosphatidyl choline;
NMR, nuclear magnetic resonance; PA, phosphatidic acid; PBC,
phosphate–borate–citrate; PC, phosphatidyl choline; PE, phosphatidyl
ethanolamine; PI, phosphatidyl inositol; PS, phosphatidyl serine; SDS,
sodium dodecyl sulfate; Tos, p-toluenesulfonyl; Trp3, tritrpticin
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peptides – constitutes a substantial component of the innate
defense system of plants and animals. A large number of
antimicrobial peptides were discovered and characterized
over the last decades [1–3]. The importance of antimicrobial
peptides stems from the growing problem of pathogenic
organisms resistant to conventional antibiotics. Moreover,
while many conventional antibiotics disable or kill bacteria
over a period of days, antimicrobial peptides act within
minutes [4]. In addition, some have a broad action spectrum,
acting against bacteria, fungi, viruses, and protozoa. All
these facts have raised increasing interest in the pharmaco-
logical application of antimicrobial peptides to explore their
potential as novel therapeutic agents. Detailed investigations
have indicated that the majority of host-defense peptides
exert their action by permeabilizing cell membranes. Thus, a
major task is to understand the molecular mechanisms un-
derlying peptide-mediated cell lysis [4–6].
The 13-residue cationic peptide tritrpticin (VRRFPWW-
WPFLRR, Trp3) is a cathelicidin with a high Arg (30%), Trp
(23%), and Pro (15%) content. This high Arg and Trp content,
together with three consecutive Trp residues, makes this pep-
tide unique. Trp3 has a broad spectrum of antimicrobial ac-
tivity against Gram-positive and Gram-negative bacteria, and
some fungi [7], as well as hemolytic activity [8].
Nuclear magnetic resonance (NMR) studies showed that,
while Trp3 interconverts between diﬀerent conformations in
solution, upon binding to sodium dodecyl sulfate (SDS) mi-
celles, it acquires a conformation with two adjacent turns
around Pro5 and Pro9. Such a positioning of the amino acids
causes Trp3 to adopt an amphipathic turn–turn structure, with
the Trp clustered together and buried in the hydrophobic core
of the micelles and the Arg residues on the opposite side of the
structure [9].
Several studies aimed at understanding the mechanism of
action of Trp3 peptide in lipid membranes have been performed
[8,10–13]. However, no clear description has been obtained thus
far. In this work, we studied the behavior of Trp3 in planar lipid
bilayers and we demonstrate that the peptide has ion channel-
like activity. To our knowledge, this ﬁnding has not been re-
ported before. The present results should contribute to the
understanding of the molecular interactions and mechanism of
action of this unique antimicrobial peptide in biological and









C-------- ----- ------- ----- ----- -----
-90 mV
172 L.C. Salay et al. / FEBS Letters 565 (2004) 171–1752. Materials and methods
2.1. Materials
Monobasic potassium phosphate, boric acid, and potassium chloride
were from Merck S.A. Industrias Quımicas (Rio de Janeiro, RJ, Bra-
zil); sodium citrate was from J.T. Baker Chemical Co. (Phillisburg, NJ,
USA). Azolectin and n-decane came from Sigma Chemical Co., St.
Louis, MO; diphytanoylphosphatidyl choline (DPhPC) was from
Avanti Polar Lipids, Alabaster, AL. Five millimolar phosphate–
borate–citrate (PBC) buﬀer, pH 7.2, prepared in Milli-Q water was
used throughout.
2.2. Peptide synthesis and sample preparation
Trp3 was synthesized manually according to the standard Na-tert-
butyloxycarbonyl (Boc) protecting group strategy [14,15] using p-tol-
uenesulfonyl (Tos) and formyl (For) Boc-amino acid derivatives of Arg
and Trp, respectively. The synthesis was performed as described in
[16]. Analytical high performance liquid chromatography (HPLC)
(Waters), LC/MS (electrospray-Micromass)-mass spectrometry (theo-
retical m=z ¼ 1902:28; found: 1902) and amino acid analysis (Bio-
chrom 20 Plus, from Amersham Biosciences) were used to check the
homogeneity of puriﬁed Trp3.
The concentration of 25 lM peptide stock solutions was determined
by UV–visible absorption in a Hitachi U-2010 spectrophotometer us-
ing a calculated molar extinction coeﬃcient (at 280 nm) of 16 500
M1 cm1. Stock solutions were frozen immediately after preparation
and stored protected from light as small aliquots at )20 C. Thawed
stock solutions were never frozen and used again [17].
2.3. Planar lipid bilayer preparation and electrical measurements
Planar lipid bilayers (or black lipid membranes – BLMs) were
formed from azolectin or from DPhPC. The approximate phospho-
lipid composition of azolectin is phosphatidyl choline (PC), 29%,
phosphatidyl ethanolamine (PE), 30%; phosphatidyl inositol (PI), 26%;
phosphatidic acid (PA), 14%; phosphatidyl serine (PS), 1% [18]. Azo-
lectin or DPhPC were dissolved in n-decane to yield a 2.5% solution.
Planar lipid bilayers were formed across a 0.2–1-mm hole in a poly-
propylene cylindrical cup inserted in a special acrylic chamber. The cup
separated two solution-ﬁlled compartments designated cis and trans
[19]. The cis compartment (to which the peptide was added) was held
at ground (0 mV) and the trans compartment was clamped to a range
of potentials. The sign of the membrane potential refers to the trans
compartment. Both compartments (cis and trans) contained the same
volume (about 3 ml) and concentration of salt in buﬀer solution (100
mM KCl in 5 mM PBC, pH 7.2, symmetrical conditions). Three mi-
croliters of 25 lM Trp3 stock solution were added to the cis side which
was stirred for 2 min using a stream of nitrogen obliquely directed over
the surface.
The transmembrane current (Im), under diﬀerent clamping poten-
tials (Vclamp), was monitored using a patch-clamp ampliﬁer (Dagan
8900) conﬁgured in voltage-clamp mode. Membrane conductance
(Gm) was obtained as Gm¼ Im/Vclamp. Data were acquired using the
Axotape 2.0.2 software and analyzed with AxoScope 8.0 (Axon
Instruments).
The channel ion selectivity was determined by measuring the open-
circuit (spontaneous) transmembrane voltage under a KCl concen-
tration diﬀerence imposed across the membrane. For this procedure a




Fig. 1. Trp3 channels in azolectin BLM. Single-channel current–time
traces under symmetric conditions: 100 mM KCl, 5 mM PBC, pH 7.2,
at diﬀerent applied voltages. Upward open levels occur at negative
applied voltages and downward open levels occur at positive applied
voltages, closed levels are indicated by dashed lines.3. Results
3.1. Trp3 channel-like activity
The ability of the antimicrobial peptide Trp3 to induce
ion conductance was tested in azolectin planar lipid bilayers.
This soy phospholipid mixture consists of zwitterionic PC
and PE and negatively charged PI, PA, and PS (see Section
2). Channel-like activity, due to the addition of an aqueous
solution of the peptide to the BLM bath, was observed as a
sudden appearance of discrete current ﬂuctuations when a
constant voltage (V) was applied across the membrane.Trp3 formed channels at both positive and negative poten-
tials. Vclamp corresponds to the potential diﬀerence between
the trans- and the cis-side (ground). By convention, a po-
sitive current reﬂects the ﬂow of cations from the cis- to the
trans-compartment or the ﬂow of anions in the opposite
direction.
Fig. 1 shows the peptide’s channel activity in azolectin BLM.
The traces present stochastic transitions between conducting
(open) and non-conducting (closed) states. The predominant
ion-channel activity is characterized by very regular and dis-
crete current steps (corresponding to openings) of uniform
amplitude and relatively long (of the order of seconds) resi-
dence times. Occasionally, multiple conductance steps were
observed, indicating the simultaneous opening of more than
one pore. A second type of channel event was also observed
exhibiting shorter dwell open times. Fig. 2 shows the voltage–
current relationship for the open channel and indicates a
non-linear behavior of I–V relationships for high positive or
negative voltage values.
Trp3 generates ion-channel activity with a predominant
conductive state with conductance G1¼ 1054 108 pS
ðn ¼ 15Þ and less predominant conductance values of G2¼
1638 96 pS ðn ¼ 6Þ; G3¼ 2532 322 pS ðn ¼ 3Þ; G4¼
508 56 pS ðn ¼ 2Þ. n is the number of regular opening events.















Fig. 2. Current–voltage relationship of the Trp3 channel formed in
azolectin BLM.
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planar bilayers of zwitterionic DPhPC (Fig. 3). In this case, the
ion-channel activity was less frequent and less evident. The
number of regular events did not allow a statistical treatment
and G was equal to 445 pS.
3.2. Trp3 channel ion selectivity
The ion selectivity of the pores formed by Trp3 was investi-
gated by establishing a KCl gradient across the membrane and
measuring the open-circuit voltage (reversal potential) across
the bilayer, using a pair of Ag–AgCl electrodes. After the in-
crease of membrane conductance induced by addition of the
peptide, successive 100 ll aliquots of 2 M KCl were introduced
in the cis side under stirring and the same volume was taken out
in order to increase the KCl concentration while keeping con-
stant the solution level so as to preserve membrane integrity.
The open-circuit voltage was measured continuously by means
of a high-impedance digital electrometer until a stable trans-
membrane voltage of 20–30 mV was obtained. At this moment
the membrane was broken and the voltage reading immediately
recorded (post-breaking voltage). Invariably, the post-breaking
voltage was half the total measured voltage, indicating 100%
selectivity of Kþ over Cl. Since the total measured voltage
across the membrane represents the sum of two electrode po-
tentials plus a membrane potential, the ﬁnding of a post-
breaking voltage equalling half the total voltage indicates that
the electrode potential is equal to the membrane potential and
both are Nernst equilibrium potentials.C----
Fig. 3. Trp3 channels in DPhPC BLM. Single-channel current–time traces u
mV. Upward open levels occur at negative applied voltage, closed level is in4. Discussion
Measurements of conductance in planar lipid bilayer are
considered a sensitive tool to study channel formation. One
main advantage is the remarkable sensitivity and speciﬁcity of
the assay. Many antimicrobial peptides as well as rationally
designed channel-forming peptides interact with BLM at very
low concentrations (106–1012 g/ml), inducing ion currents
[20–23].
In this study, incorporation of the antimicrobial peptide
Trp3 into azolectin planar lipid bilayers (which carry a net
negative surface charge) induced the appearance of a pre-
dominantly rectangular, stable, and regular current ﬂuctua-
tion, as well as much less frequent and irregular current
ﬂuctuations (Fig. 1). This ﬁnding indicates that Trp3 is a pore-
forming peptide, displaying ion channel-like activity with very
high single-channel conductance, ranging from a few hundreds
to about two thousand picosiemens. Other relatively small
peptides form channels: the cationic Ab amyloid peptides form
large conductance multistate channels (10–2000 pS [23,24]);
the rabbit neutrophil peptide (NP-1) gives rise to channels
whose conductance varies from 10 to 1000 pS [25], magainin 1
originates channels with two levels of conductance, 366 and
683 pS [26], and the antimicrobial peptide indolicidin, a 13-
residue Trp-rich peptide, forms discrete channels with con-
ductance values ranging from 50 to 150 pS [27].
It should be noticed that azolectin contains a considerable
amount of negatively charged head groups, as usually found
on the bacterial cell surface (PI, 26%; PA, 14%; PS, 1% [18]).
However, preliminary data for the zwitterionic phospholipid
DPhPC indicate pronounced, but less well-deﬁned and less
frequent, ion channel activity (Fig. 3). This is in agreement
with the lesser leakage eﬀect of Trp3 in zwitterionic dioleoyl-
phosphatidyl choline:dioleoylphosphatidyl ethanolamine
(DOPC:DOPE) vesicles [11].
Schibli et al. [11] have reported studies of the interaction
between Trp3 and other Trp-rich antimicrobial peptides with
membranes of variable lipid composition. Fluorescence studies
of maximum emission wavelengths, red-edge eﬀects, quenching
by water-soluble and membrane-embedded quenchers showed
that Trp3 binds preferentially to membranes containing neg-
atively charged dioleoylphosphatidyl glycerol (DOPG), and, to
a lesser extent, to DOPC:DOPE. Moreover, peptide-induced
leakage from the inner aqueous compartment of large unila-
mellar vesicles indicated that the eﬀect followed the order:
DOPE:DOPG>DOPC:DOPGDOPC:DOPE. In addition,
Trp3 had the largest eﬀect among the studied peptides, in-
cluding indolicidin. These data are in agreement with our
observation of the pronounced channel activity of Trp3 in
negatively charged azolectin BLM and with the fact that Trp3
ion channels display larger conductance (this work) than those1 s
1 p A
nder symmetric conditions: 100 mM KCl, 5 mM PBC, pH 7.2, at )80
dicated by dashed line.
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[11] showed that Trp3 has an approximately twofold higher
antimicrobial activity than indolicidin. Furthermore, the very
low leakage induced by Trp3 in DOPC:DOPE membranes [11]
correlates well with the presently found less frequent and less
pronounced ion-channel activity of the peptide in DPhPC
(Fig. 3).
In the work by Schibli et al. [11], the fact that Trp3 dis-
played the largest red-edge eﬀect was interpreted as reﬂecting
the peptide more stable insertion in the interface, which re-
sulted in it being more motionally restricted. This behavior
was proposed as the explanation for Trp3 being the most
lytic among the Trp-rich peptides. This fact could also ac-
count for the stable and regular ion-channel activity of the
Trp3 pore (Fig. 1), suggesting a ﬁxed stoichiometry (i.e., a
ﬁxed number of peptides per pore). The symmetric supra-
linear current-voltage relationship of the open-channel
(Fig. 2) remains to be explained. Nevertheless, it should be
noticed that this is a common ﬁnding in many types of ion
channels [28].
The ion-selectivity assay indicates that Trp3 forms a cation-
selective pore. This is an unexpected ﬁnding, considering the
cationic nature of the peptide. Ion selectivity is frequently
found but not always straightforwardly correlated with the
sign of charged sites in the channel. This lack of correlation is
probably due to the fact that channels use a variety of mech-
anisms to discriminate between ions, and the selectivity often
reﬂects diﬀerent aspects of the channel structure [29]. Several
positively charged peptides form cation-selective channels: a
segment of the sodium channel polypeptide [30], synthetic a-
helical peptides containing Arg as the main charged amino
acid residue [31], magainin 2, a natural antibiotic [32]. The
high Trp3-induced conductance suggests a large pore diameter
and a low interionic discrimination based on the small diﬀer-
ence of the Pauling radii of the conducting ions (Kþ 1.33 A;
Cl 1.81 A). The selectivity would not be determined by the
dehydration energy of the ions [33] either, since the hydration
energies [34] of chloride (DHhydration¼)82 kcal/mol) and po-
tassium (DHhydration¼)85 kcal/mol) are very similar.
The present results bring about several questions: (1) What
is the pore structure and dynamics? (2) What is the molecular
mechanism of pore formation? (3) What is the molecular basis
of ion selectivity? Several models have been proposed for the
mechanism of action of antimicrobial peptides in lipid mem-
branes [35–39]. The barrel-stave model involves a bundle of
membrane-spanning amphipathic secondary structures (usu-
ally a-helices) with their polar faces lining the pore lumen. This
model is illustrated by alamethicin, whose self-assembly in li-
pid bilayers generates ion channels with reproducible discrete
multiple conductance states [40]. Trp3 is a 13-residue peptide
not expected to span the lipid bilayer as an a-helix. In an ex-
tended conformation (as a b-sheet) its length would be ca. 4.55
nm, enough to span the bilayer, whose hydrocarbon core
thickness is approximately 3.5 nm. However, due to its sizeable
dipole and quadrupole moments, as well as hydrogen-bonding
potential [41], the tryptophan indole moiety displays a pref-
erence for the membrane interface rather than a more hydro-
phobic environment, which would be energetically unfavorable
[42]. The organization of Trp3 molecules in a bilayer-spanning
form would require the tryptophan residues to be located in a
more hydrophobic environment, therefore being energetically
unfavorable.Indeed, spectroscopic data do not provide evidence for b-
sheet conformation for Trp3 bound to SDS micelles [9]. NMR
studies [9] showed that the peptide forms two adjacent turns
around the two Pro residues; the ﬁrst turn involves residues 4–
7, followed by a second 310-helical turn involving residues 8–
11. The hydrophobic residues are clustered together and are
clearly separated from the basic Arg residues, forming an
amphipathic structure. NMR measurements in the presence of
a spin label evinced that Trp3 lies near the micelle surface [9].
A similar location was also determined in lipid bilayers by
ﬂuorescence quenching [11].
Nevertheless, Trp3 is able to induce leakage of solutes lo-
cated in the aqueous inner compartment of liposomes [11] and
the present results clearly demonstrate that the peptide can
form ion channels in negatively charged and zwitterionic lipid
bilayers. A second model of membrane permeabilization has
been proposed for several a-helical peptides. According to this
model, known as the Shai–Matsuzaki–Huang (SMH) model
[1], initially the peptides bind at the membrane interface, with
the helix axis approximately parallel to the bilayer surface. As
discussed by Matsuzaki [43], this location pushes the lipid
polar head groups aside, leading to the local induction of
positive curvature strain. The unfavorable membrane-defor-
mation energy reaches a critical value and several peptide
molecules with surrounding lipids form a dynamic, peptide-
lipid supramolecular complex pore [44] or a toroidal pore
[35,45] whose polar surface is formed by both peptides and
lipid. In this model the participation of negatively charged
phospholipid head groups in toroidal pore formation might
contribute to the pore cation selectivity.
Although this mechanism has not been veriﬁed for non-a-
helical peptides yet, Schibli et al. [11] suggested that this could
be the mechanism for Trp3-induced membrane permeabiliza-
tion, especially in view of its Trp residues being located mostly
at the membrane interface. However, the authors do point out
that the leakage eﬃciency is higher for DOPE:DOPG than for
DOPC:DOPG membranes. This observation is not in agree-
ment with the notion that toroidal pore formation would be
favored by positive curvature-inducing PC and inhibited by
negative curvature-inducing PE [37,43].
Clearly, the lipid composition of bacterial membranes is
complex and variable. Since a large number of bacterial species
contain zwitterionic PE and negatively charged PG as major
phospholipids, these lipids have been often used in model
membranes for studies with antimicrobial peptides. However,
in view of the current ideas about the requirement of lipids that
favor positive curvature in order to form a toroidal pore, the
latter have also been used in model membrane systems (e.g.,
PC, as in the work by Schibli et al. [11]). Azolectin contains
lipids found in bacterial membranes, albeit sometimes in
smaller amounts. Both positive (PC, 29%; PI, 26%; PA, 14%;
PS, 1%, at the pH and ionic strength of the present experi-
ments) and negative (PE, 30%) curvature-inducing lipids are
present in azolectin [46]. Thus, although it does not contain
PG, the negatively charged lipids found in azolectin (PI, PA,
and PS, a total of 41%) favor positive curvature, like PG,
under physiological conditions [46]. It should also be pointed
out that Trp3 has been proposed to induce membrane positive
curvature [41].
Electrostatic interactions between positively charged Trp3
and negatively charged phospholipid head groups would favor
the displacement of these lipids to the conducting pathway
L.C. Salay et al. / FEBS Letters 565 (2004) 171–175 175and, consequently, contribute to attract cations over anions to
the formed pore. The high stability of the pores formed by
Trp3 would be favored by a peptide–lipid composite pore with
the peptide located at the interface as in the SMH toroidal
pore model.
Correlating structure and function of peptides is crucial for
understanding the underlying molecular and physicochemical
basis of their mode of action. This work demonstrates that
Trp3 can act as a pore-forming peptide. However, in the light
of the existing data, a complete model cannot be proposed for
the Trp3 pore structure and dynamics. Aiming at elucidating
these questions, we are presently conducting detailed spectro-
scopic and electrophysiological studies of Trp3 conformational
and ion-channel properties.
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